As one of the largest professional media and service platforms in the medical device industry,"Mtech Home"has been closely following the development of China's medical technology since its establishment over a decade ago,recording one memorable"highlight"moment after another.Based on nearly 3,000 industry news articles published in 2024,and considering multiple dimensions such as"innovation content,""technical advantages,"and"industry impact,"and in accordance with the suggestions of experts and the recognition of readers,the top ten most valuable innovative products were selected in nine fields:surgical robots,imaging,surgery and orthopedics,radiotherapy,endoscopy,implantable and cardiovascular devices,clinical,AI and digitalization,and ESG.

On April 8, 2025, the 91st China International Medical Equipment Fair (CMEF) will be grandly opened at the Shanghai National Convention and Exhibition Center. As a weather vane in the global medical and health field, this exhibition, with the theme of "Innovative Technology, Leading the Future with Intelligence", attracted nearly 5,000 international companies to participate in the exhibition and over 200,000 professional visitors to participate in the event. On the occasion of this grand event, the Medical Device Innovation Center of Lingang New Area will host the "High-quality Medical Device Global Expansion Summit Forum" at the main venue, and officially release the list of shortlisted companies for the "Guidelines for the Selection of China's High-quality Medical Devices Overseas (2025)" - Shanghai Jinhai Medical Technology Co., Ltd. was successfully selected and became a benchmark representative of China's high-quality medical devices overseas.

On February 7,2025,the Department of Joint Minimally Invasive Surgery and Sports Medicine at Shengjing Hospital Affiliated to China Medical University left a significant mark in the development of Northeast Asia's medical field by successfully completing the first 4K 3D arthroscopic anterior cruciate ligament(ACL)reconstruction surgery in the three northeastern provinces.This surgery,enabled by Jinhai Medical's 4K 3D arthroscopy system,synchronously displayed three-dimensional stereoscopic images and 4K ultra-high-definition images,achieving precise localization and minimally invasive operation of the internal structures of the knee joint.This not only ushers in a new era of"intelligent and stereoscopic visualization"for arthroscopic surgery in the Northeast region but also radiates from Shenyang to the entire Northeast Asia,demonstrating a leap in regional medical technology.

The 15th China Medical Industry Data Release Conference and Medical Science and Technology Innovation Conference,hosted by the"China Medical Equipment"magazine,was held in Beijing.Jinhai Medical won the Most Investment Value Award at the 10th China Medical Industry Innovation Competition in 2024.At the same time,Jinhai Medical also received the honorary title of"Top 10 National Medical Equipment Upgrade Solutions"at the 15th"China Good Medical Engineer-China Excellent Clinical Engineering Team".

On January 2,2025,the Jiading District People's Government held the"Empowering Together,Winning the Future"2025 Jiading District Outstanding Enterprise Plaque Presentation Ceremony.Lu Fangzhou,the Secretary of the Jiading District Committee of Shanghai,Gao Xiang,the Deputy Secretary and District Head,and other relevant leaders attended the meeting.

On March 4,2025,the Department of Joint Minimally Invasive Surgery and Sports Medicine at the Second Affiliated Hospital of Harbin Medical University(hereinafter referred to as"HMUH")announced the successful completion of the first 3D arthroscopic knee surgery in the three northeastern provinces.The technology,by synchronously presenting 3D stereoscopic images and 4K ultra-high-definition images,has achieved accurate localization and minimally invasive treatment of knee joint lesions,marking the official entry of joint arthroscopic surgery in the Northeast region into the"intelligent and stereoscopic visualization"era.

As one of the largest professional media and service platforms in the medical device industry,"Medical Device Home"has closely followed the development of medical technology in China over its more than ten years of establishment,recording one memorable"highlight"moment after another.Based on nearly 3,000 industry news articles published in 2024,

KEENSEA Medical Technology recently announced that its wholly-owned subsidiary, KEENSEA Xiehuan, has recently entered into a general sales agreement with Sinopharm LingShang. Under this agreement, KEENSEA Xiehuan has granted Sinopharm LingShang the exclusive distributorship for several of the Group's high-end medical devices in China, with the term extending to October of this year. Leveraging Sinopharm LingShang's

At the"9th SmartKarma Capital Market Annual Conference and Listed Companies Awards Ceremony,"KEENSEA Medical Technology(02225)was honored with the title of"Most Valuable Pharmaceutical and Medical Company."As a highly acclaimed enterprise within the industry,KEENSEA Medical Technology has garnered extensive recognition from investors for its remarkable technological innovation and outstanding market performance.